Boreal Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$200K Buy
167
+8
+5% +$8.17K 0.15% 114
2026
Q1
$146K Hold
159
0.12% 134
2025
Q4
$171K Hold
159
0.13% 134
2025
Q3
$121K Hold
159
0.1% 154
2025
Q2
$124K Buy
+159
New +$124K 0.1% 155

Other funds holding LLY

Boreal Capital Management's LLY Position: Q2 2026 in Review

Boreal Capital Management increased its Eli Lilly (LLY) stake by 5% in Q2 2026, buying an estimated $8.17K and bringing the position to 167 shares worth $200K. The position accounts for 0.15% of the portfolio, ranked #114.

Boreal Capital Management first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Boreal Capital Management held 167 shares of Eli Lilly worth $200K as of Q2 2026.
  • Boreal Capital Management bought 8 Eli Lilly shares in Q2 2026, an estimated $8.17K.
  • Eli Lilly made up 0.15% of Boreal Capital Management's portfolio in Q2 2026, its #114 holding.
  • Boreal Capital Management first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Boreal Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.